silybin has been researched along with galactose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dube, D; Goyal, AK; Khatri, K; Mishra, N; Vyas, SP | 1 |
| Hao, W; Ikejima, T; Liu, W; Onodera, S; Tashiro, S; Wang, Q; Zou, L | 1 |
2 other study(ies) available for silybin and galactose
| Article | Year |
|---|---|
Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin.
Topics: Animals; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Galactose; Liposomes; Liver; Male; Rats; Silybin; Silymarin; Tissue Distribution | 2010 |
Inhibiting NF-κB activation and ROS production are involved in the mechanism of silibinin's protection against D-galactose-induced senescence.
Topics: Aging; Animals; Antioxidants; Autophagy; Cognition; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Galactose; Hippocampus; Maze Learning; Mice; NF-kappa B; Reactive Oxygen Species; Silybin; Silymarin; Tumor Suppressor Protein p53 | 2011 |